{"id":"https://openalex.org/W2178588353","doi":"https://doi.org/10.3389/fimmu.2015.00578","title":"The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer","display_name":"The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer","publication_year":2015,"publication_date":"2015-11-17","ids":{"openalex":"https://openalex.org/W2178588353","doi":"https://doi.org/10.3389/fimmu.2015.00578","mag":"2178588353","pmid":"https://pubmed.ncbi.nlm.nih.gov/26635792","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4648067"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2015.00578","doi":"https://doi.org/10.3389/fimmu.2015.00578","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2015.00578","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2015.00578/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2015.00578/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007244861","display_name":"Katayoun Rezvani","orcid":"https://orcid.org/0000-0002-9599-2246","observed_orcids":["https://orcid.org/0000-0002-9599-2246"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katayoun Rezvani","raw_affiliation_strings":["Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015555817","display_name":"Rayne Helen Rouce","orcid":"https://orcid.org/0000-0002-0670-0599","observed_orcids":["https://orcid.org/0000-0002-0670-0599"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rayne H. Rouce","raw_affiliation_strings":["Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine , Houston, TX , USA ; Center for Cell and Gene Therapy, Baylor College of Medicine Houston Methodist Hospital and Texas Children's Hospital , Houston, TX , USA","Center for Cell and Gene Therapy, Baylor College of Medicine Houston Methodist Hospital and Texas Children's Hospital, Houston, TX, USA","Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine , Houston, TX , USA ; Center for Cell and Gene Therapy, Baylor College of Medicine Houston Methodist Hospital and Texas Children's Hospital , Houston, TX , USA","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]},{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine Houston Methodist Hospital and Texas Children's Hospital, Houston, TX, USA","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]},{"raw_affiliation_string":"Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5007244861"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.7748,"has_fulltext":true,"cited_by_count":274,"citation_normalized_percentile":{"value":0.93369664,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"6","issue":null,"first_page":"578","last_page":"578"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/nk-cell-therapy","display_name":"NK cell therapy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9520000219345093},{"id":"https://openalex.org/keywords/car-nk-cells","display_name":"CAR-NK cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/adoptive-nk-cell-therapy","display_name":"adoptive NK cell therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8379999995231628},{"id":"https://openalex.org/keywords/trispecific-antibodies","display_name":"trispecific antibodies","score":0.9769999980926514},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8560000061988831},{"id":"https://openalex.org/keywords/nk-cell-persistence","display_name":"NK cell persistence","score":0.7519999742507935},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6779576539993286},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6481132507324219},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.5575166344642639},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5558623671531677},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5284269452095032},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5001301765441895},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.47717633843421936},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4547629952430725},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4545818865299225},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.44167229533195496},{"id":"https://openalex.org/C206191192","wikidata":"https://www.wikidata.org/wiki/Q17149636","display_name":"NK-92","level":5,"score":0.4306888282299042},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.4162313640117645},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3269743323326111},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3204936981201172},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.26640668511390686},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11869966983795166},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2015.00578","doi":"https://doi.org/10.3389/fimmu.2015.00578","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2015.00578","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2015.00578/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4648067","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4648067","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:26635792","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26635792","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1b8a18cc32354cf5a305ed0bb97d4762","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1b8a18cc32354cf5a305ed0bb97d4762","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 6 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2015.00578","doi":"https://doi.org/10.3389/fimmu.2015.00578","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2015.00578","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2015.00578/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6526681941","display_name":null,"funder_award_id":"CA100632","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G7528975383","display_name":null,"funder_award_id":"1LRF CDGA","funder_id":"https://openalex.org/F4320306378","funder_display_name":"Lymphoma Research Foundation"},{"id":"https://openalex.org/G9000869486","display_name":"Training In Cell and Gene Therapy","funder_award_id":"T32HL092332","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000915301","display_name":"SPORE in Lymphoma","funder_award_id":"P50CA126752","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306378","display_name":"Lymphoma Research Foundation","ror":"https://ror.org/02y7bdg71"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2178588353.pdf","grobid_xml":"https://content.openalex.org/works/W2178588353.grobid-xml"},"referenced_works_count":119,"referenced_works":["https://openalex.org/W109340176","https://openalex.org/W1508110130","https://openalex.org/W1542501019","https://openalex.org/W1573309974","https://openalex.org/W1581623404","https://openalex.org/W1795190780","https://openalex.org/W1826995994","https://openalex.org/W1895193514","https://openalex.org/W1902091068","https://openalex.org/W1927751365","https://openalex.org/W1965962344","https://openalex.org/W1966128754","https://openalex.org/W1967455230","https://openalex.org/W1967995010","https://openalex.org/W1968139996","https://openalex.org/W1969740606","https://openalex.org/W1971514891","https://openalex.org/W1974344836","https://openalex.org/W1974562505","https://openalex.org/W1977277180","https://openalex.org/W1978649225","https://openalex.org/W1978755540","https://openalex.org/W1980311294","https://openalex.org/W1981137720","https://openalex.org/W1985322758","https://openalex.org/W1985981664","https://openalex.org/W1988224733","https://openalex.org/W1989993418","https://openalex.org/W1990428948","https://openalex.org/W1993658046","https://openalex.org/W1995515999","https://openalex.org/W1997849135","https://openalex.org/W1998414899","https://openalex.org/W2011416965","https://openalex.org/W2014135188","https://openalex.org/W2015912224","https://openalex.org/W2019525397","https://openalex.org/W2020973179","https://openalex.org/W2021377837","https://openalex.org/W2023068069","https://openalex.org/W2023082289","https://openalex.org/W2023208511","https://openalex.org/W2024967297","https://openalex.org/W2025635581","https://openalex.org/W2025950737","https://openalex.org/W2028140189","https://openalex.org/W2029458815","https://openalex.org/W2036088843","https://openalex.org/W2036386987","https://openalex.org/W2038038101","https://openalex.org/W2040638238","https://openalex.org/W2044360617","https://openalex.org/W2045664257","https://openalex.org/W2047353087","https://openalex.org/W2051657147","https://openalex.org/W2052605694","https://openalex.org/W2056315817","https://openalex.org/W2057776379","https://openalex.org/W2058075271","https://openalex.org/W2059142229","https://openalex.org/W2059467769","https://openalex.org/W2062176699","https://openalex.org/W2064316406","https://openalex.org/W2070120246","https://openalex.org/W2077217249","https://openalex.org/W2081047303","https://openalex.org/W2085781143","https://openalex.org/W2088154452","https://openalex.org/W2090083883","https://openalex.org/W2090858884","https://openalex.org/W2091149983","https://openalex.org/W2091675007","https://openalex.org/W2092215629","https://openalex.org/W2093494939","https://openalex.org/W2098405656","https://openalex.org/W2102470992","https://openalex.org/W2102873264","https://openalex.org/W2105400883","https://openalex.org/W2105494088","https://openalex.org/W2105557870","https://openalex.org/W2108207655","https://openalex.org/W2112101851","https://openalex.org/W2112574922","https://openalex.org/W2113170011","https://openalex.org/W2114908650","https://openalex.org/W2117453905","https://openalex.org/W2119607003","https://openalex.org/W2120072658","https://openalex.org/W2121462531","https://openalex.org/W2124416339","https://openalex.org/W2124637769","https://openalex.org/W2125739592","https://openalex.org/W2126153224","https://openalex.org/W2128402413","https://openalex.org/W2129702476","https://openalex.org/W2130354176","https://openalex.org/W2132835748","https://openalex.org/W2134446851","https://openalex.org/W2137231722","https://openalex.org/W2140516324","https://openalex.org/W2141436376","https://openalex.org/W2142210663","https://openalex.org/W2144436556","https://openalex.org/W2144872368","https://openalex.org/W2146494327","https://openalex.org/W2148523692","https://openalex.org/W2155044513","https://openalex.org/W2158513713","https://openalex.org/W2165144791","https://openalex.org/W2165635676","https://openalex.org/W2165813814","https://openalex.org/W2165920713","https://openalex.org/W2211008635","https://openalex.org/W2278523282","https://openalex.org/W2338985623","https://openalex.org/W2463048000","https://openalex.org/W2941307081","https://openalex.org/W6604469163","https://openalex.org/W6719112229"],"related_works":["https://openalex.org/W2772196220","https://openalex.org/W4409534757","https://openalex.org/W2792861145","https://openalex.org/W4415130041","https://openalex.org/W4206023597","https://openalex.org/W4281396741","https://openalex.org/W3087526274","https://openalex.org/W4287307650","https://openalex.org/W2753630019","https://openalex.org/W4313463398"],"abstract_inverted_index":{"Natural":[0],"killer":[1],"(NK)":[2],"cells":[3,93,142,188,218,234],"are":[4,174,214,250],"essential":[5],"components":[6],"of":[7,27,44,58,64,69,111,116,121,126,133,139,156,177,186,209,256,265,284],"the":[8,33,42,56,109,124,131,137,153,165,175,181,202,254,263,282,288],"innate":[9],"immune":[10],"system":[11],"and":[12,72,145,171,205,269],"play":[13],"a":[14,119],"critical":[15],"role":[16],"in":[17,24,55,108,147,262],"host":[18,169],"immunity":[19],"against":[20,246],"cancer.":[21,45],"Recent":[22],"progress":[23],"our":[25],"understanding":[26],"NK":[28,37,59,84,92,127,141,157,166,187,211,230,257,266,276],"cell":[29,60,128,167,267,277],"immunobiology":[30],"has":[31,197],"paved":[32],"way":[34],"for":[35,41,130,222,253],"novel":[36],"cell-based":[38,158],"therapeutic":[39,154],"strategies":[40,162],"treatment":[43,132],"In":[46,86,180],"this":[47],"review,":[48],"we":[49],"will":[50,279],"focus":[51],"on":[52],"recent":[53,260],"advances":[54,261],"field":[57,264],"immunotherapy,":[61],"including":[62],"augmentation":[63],"antibody-dependent":[65],"cellular":[66],"cytotoxicity,":[67],"manipulation":[68],"receptor-mediated":[70],"activation,":[71],"adoptive":[73,223],"immunotherapy":[74,129,159,278,286],"with":[75,259],"ex":[76],"vivo-expanded,":[77],"chimeric":[78],"antigen":[79],"receptor":[80],"(CAR)-engineered,":[81],"or":[82,240],"engager-modified":[83],"cells.":[85],"contrast":[87],"to":[88,143,151,163,189,192,219,228,236,281],"T":[89],"lymphocytes,":[90],"donor":[91],"do":[94],"not":[95],"attack":[96],"non-hematopoietic":[97],"tissues,":[98],"suggesting":[99],"that":[100,275],"an":[101],"NK-mediated":[102],"antitumor":[103,195],"effect":[104],"can":[105],"be":[106],"achieved":[107],"absence":[110],"graft-vs.-host":[112],"disease.":[113],"Despite":[114],"reports":[115],"clinical":[117],"efficacy,":[118],"number":[120],"factors":[122],"limit":[123],"application":[125],"cancer,":[134],"such":[135],"as":[136],"failure":[138],"infused":[140],"expand":[144],"persist":[146],"vivo.":[148],"Therefore,":[149],"efforts":[150],"enhance":[152],"benefit":[155],"by":[160],"developing":[161],"manipulate":[164],"product,":[168],"factors,":[170],"tumor":[172,233],"targets":[173],"subject":[176],"intense":[178],"research.":[179],"preclinical":[182],"setting,":[183],"genetic":[184],"engineering":[185],"express":[190,220],"CARs":[191,221],"redirect":[193,229],"their":[194],"specificity":[196],"shown":[198],"significant":[199],"promise.":[200],"Given":[201],"short":[203],"lifespan":[204],"potent":[206],"cytolytic":[207],"function":[208],"mature":[210],"cells,":[212],"they":[213],"attractive":[215],"candidate":[216],"effector":[217],"immunotherapies.":[224],"Another":[225],"innovative":[226],"approach":[227],"cytotoxicity":[231,245],"towards":[232],"is":[235,273],"create":[237],"either":[238],"bispecific":[239],"trispecific":[241],"antibodies,":[242],"thus":[243],"augmenting":[244],"tumor-associated":[247],"antigens.":[248],"These":[249],"exciting":[251],"times":[252],"study":[255],"cells;":[258],"biology":[268],"translational":[270],"research,":[271],"it":[272],"likely":[274],"move":[280],"forefront":[283],"cancer":[285],"over":[287],"next":[289],"few":[290],"years.":[291]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":24},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":32},{"year":2019,"cited_by_count":37},{"year":2018,"cited_by_count":29},{"year":2017,"cited_by_count":39},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}